Yu Zeng
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zeng, Yu
NCT05364918: Clinical Study On Acute Radiotherapy-Induced Oral Mucositis In Patients With Locally Advanced Head And Neck Tumors

Completed
3
100
RoW
Jeksung combined with anti-radiation spray
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Head and Neck Cancer
08/22
03/23
NCT06155084: A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Recruiting
1/2
84
RoW
HP518 - Dose Escalation, Part 1 - Dose Escalation, HP518 -Dose Expansion, Part 2 - Dose Expansion Oral tablet(s)
Hinova Pharmaceuticals Inc.
Metastatic Castration-resistant Prostate Cancer
10/25
09/26
NCT04967027: Phase 1 Trial for Tumor Treating Field for Drug/Radiation Resistant Brain Metastases

Recruiting
1
5
RoW
ASCLU-300 TTF
Xiangya Hospital of Central South University
Brain Metastases
08/22
12/22
NCT05858385: Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

Recruiting
N/A
700
RoW
Intervention based on key factors identified by the severe RIOM prediction model
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Nasopharyngeal Carcinoma by AJCC V8 Stage, Radiation Induced Mucositis
06/24
12/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zeng, Yu
NCT05364918: Clinical Study On Acute Radiotherapy-Induced Oral Mucositis In Patients With Locally Advanced Head And Neck Tumors

Completed
3
100
RoW
Jeksung combined with anti-radiation spray
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Head and Neck Cancer
08/22
03/23
NCT06155084: A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Recruiting
1/2
84
RoW
HP518 - Dose Escalation, Part 1 - Dose Escalation, HP518 -Dose Expansion, Part 2 - Dose Expansion Oral tablet(s)
Hinova Pharmaceuticals Inc.
Metastatic Castration-resistant Prostate Cancer
10/25
09/26
NCT04967027: Phase 1 Trial for Tumor Treating Field for Drug/Radiation Resistant Brain Metastases

Recruiting
1
5
RoW
ASCLU-300 TTF
Xiangya Hospital of Central South University
Brain Metastases
08/22
12/22
NCT05858385: Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

Recruiting
N/A
700
RoW
Intervention based on key factors identified by the severe RIOM prediction model
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Nasopharyngeal Carcinoma by AJCC V8 Stage, Radiation Induced Mucositis
06/24
12/24

Download Options